|
|
|
|
||
Combination of ZEN-3694 with CDK4/6 inhibitors reverses resistance in ER-positive breast cancer https://pressfrom.info/au/lifestyle/health/-230957-lillys-breast-cancer-drug-succeeds-in-study-shares-rise-11.html 6/17/20
https://www.marketbeat.com/instant-alerts/nyse-lly-a-buy-or-sell-right-now/ 6/29/20 Eli Lilly And Co (NYSE:LLY) had its price objective upped by stock analysts at Mizuho from $155.00 to $164.00 in a research report issued on Monday, The Fly reports. The firm currently has a "neutral" rating on the stock. Mizuho's price objective points to a potential upside of 0.72% from the company's previous close. 6/29/20 https://www.zenithepigenetics.com/upload/media_element/120/01/aacr-2020-1750-abstract-2346.pdf |
return to message board, top of board |